_id

690f349fccc777a4e85d1686

Ticker

BFRI

Name

Biofrontera Inc

Exchange

NASDAQ

Address

120 Presidential Way, Woburn, MA, United States, 01801

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

https://www.biofrontera-us.com

Description

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Last Close

0.8129

Volume

71322

Current Price

0.8123

Change

-0.07380981670561372

Last Updated

2025-11-28T12:50:45.223Z

Image

data:image/webp;base64,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

Ipo Date

2021-10-29T00:00:00.000Z

Market Cap

9184703

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.7895714285714286

Sentiment Sources

7

Rating

4.5

Target Price

6

Strong Buy

1

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

6988000

Cost Of Revenue

1922000

Gross Profit

5066000

Operating Expenses

11344000

Operating Income

-6278000

Interest Expense

111000

Pretax Income

-6643000

Net Income

-6649000

Eps

-0.6169769909060616

Dividends Per Share

-

Shares Outstanding

11648323

Income Tax Expense

6000

EBITDA

-6333000

Operating Margin

-89.83972524327419

Total Other Income Expense Net

-365000

Cash

3417000

Short Term Investments

10000

Receivables

2995000

Inventories

4329000

Total Current Assets

14413000

Property Plant Equipment

508000

Total Assets

15415000

Payables

3639000

Short Term Debt

307000

Long Term Debt

4462000

Total Liabilities

17996000

Equity

-2581000

Depreciation

207000

Change In Working Capital

1955000

Cash From Operations

-3823000

Capital Expenditures

1000

Cash From Investing

1000

Cash From Financing

0

Net Change In Cash

-3822000

PE

-

PB

-3.3941926125920183

ROE

257.61332816737695

ROA

-43.133311709373984

FCF

-3824000

Fcf Percent

-0.5472238122495707

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

1.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.3

Garp Investing Score

2.5

Growth Investing Score

2.5

Momentum Investing Score

5

Net Net Investing Score

1

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

6988000

Quarters > 0 > income Statement > cost Of Revenue

1922000

Quarters > 0 > income Statement > gross Profit

5066000

Quarters > 0 > income Statement > operating Expenses

11344000

Quarters > 0 > income Statement > operating Income

-6278000

Quarters > 0 > income Statement > interest Expense

111000

Quarters > 0 > income Statement > pretax Income

-6643000

Quarters > 0 > income Statement > net Income

-6649000

Quarters > 0 > income Statement > eps

-0.6169769909060616

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

10776739

Quarters > 0 > income Statement > income Tax Expense

6000

Quarters > 0 > income Statement > EBITDA

-6333000

Quarters > 0 > income Statement > operating Margin

-89.83972524327419

Quarters > 0 > income Statement > total Other Income Expense Net

-365000

Quarters > 0 > balance Sheet > cash

3417000

Quarters > 0 > balance Sheet > short Term Investments

10000

Quarters > 0 > balance Sheet > receivables

2995000

Quarters > 0 > balance Sheet > inventories

4329000

Quarters > 0 > balance Sheet > total Current Assets

14413000

Quarters > 0 > balance Sheet > property Plant Equipment

508000

Quarters > 0 > balance Sheet > total Assets

15415000

Quarters > 0 > balance Sheet > payables

3639000

Quarters > 0 > balance Sheet > short Term Debt

307000

Quarters > 0 > balance Sheet > long Term Debt

4462000

Quarters > 0 > balance Sheet > total Liabilities

17996000

Quarters > 0 > balance Sheet > equity

-2581000

Quarters > 0 > cash Flow > net Income

-6649000

Quarters > 0 > cash Flow > depreciation

207000

Quarters > 0 > cash Flow > change In Working Capital

1955000

Quarters > 0 > cash Flow > cash From Operations

-3823000

Quarters > 0 > cash Flow > capital Expenditures

1000

Quarters > 0 > cash Flow > cash From Investing

1000

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

-3822000

Quarters > 0 > ratios > PE

-0.6169769909060616

Quarters > 0 > ratios > PB

-3.3941926125920183

Quarters > 0 > ratios > ROE

257.61332816737695

Quarters > 0 > ratios > ROA

-43.133311709373984

Quarters > 0 > ratios > FCF

-3824000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-0.5472238122495707

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

9030000

Quarters > 1 > income Statement > cost Of Revenue

2380000

Quarters > 1 > income Statement > gross Profit

6650000

Quarters > 1 > income Statement > operating Expenses

11729000

Quarters > 1 > income Statement > operating Income

-5079000

Quarters > 1 > income Statement > interest Expense

115000

Quarters > 1 > income Statement > pretax Income

-5303000

Quarters > 1 > income Statement > net Income

-5324000

Quarters > 1 > income Statement > eps

-0.5693169597319463

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

9351557

Quarters > 1 > income Statement > income Tax Expense

21000

Quarters > 1 > income Statement > EBITDA

-4966000

Quarters > 1 > income Statement > operating Margin

-56.245847176079735

Quarters > 1 > income Statement > total Other Income Expense Net

-224000

Quarters > 1 > balance Sheet > cash

7239000

Quarters > 1 > balance Sheet > short Term Investments

9000

Quarters > 1 > balance Sheet > receivables

3955000

Quarters > 1 > balance Sheet > inventories

4027999

Quarters > 1 > balance Sheet > total Current Assets

18815000

Quarters > 1 > balance Sheet > property Plant Equipment

766000

Quarters > 1 > balance Sheet > total Assets

20142000

Quarters > 1 > balance Sheet > payables

4938000

Quarters > 1 > balance Sheet > short Term Debt

443000

Quarters > 1 > balance Sheet > long Term Debt

4338000

Quarters > 1 > balance Sheet > total Liabilities

24810000

Quarters > 1 > balance Sheet > equity

-4668000

Quarters > 1 > cash Flow > net Income

-5324000

Quarters > 1 > cash Flow > depreciation

222000

Quarters > 1 > cash Flow > change In Working Capital

1916000

Quarters > 1 > cash Flow > cash From Operations

-3045000

Quarters > 1 > cash Flow > capital Expenditures

1000

Quarters > 1 > cash Flow > cash From Investing

-1000

Quarters > 1 > cash Flow > cash From Financing

8500000

Quarters > 1 > cash Flow > net Change In Cash

5454000

Quarters > 1 > ratios > PE

-0.5693169597319463

Quarters > 1 > ratios > PB

-1.6285091442373607

Quarters > 1 > ratios > ROE

114.05312767780633

Quarters > 1 > ratios > ROA

-26.432330453778174

Quarters > 1 > ratios > FCF

-3046000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.33732004429678847

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

8588000

Quarters > 2 > income Statement > cost Of Revenue

3075000

Quarters > 2 > income Statement > gross Profit

5513000

Quarters > 2 > income Statement > operating Expenses

10060000

Quarters > 2 > income Statement > operating Income

-4547000

Quarters > 2 > income Statement > interest Expense

120000

Quarters > 2 > income Statement > pretax Income

-4204000

Quarters > 2 > income Statement > net Income

-4203000

Quarters > 2 > income Statement > eps

-0.7619190571129304

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

5516334

Quarters > 2 > income Statement > income Tax Expense

-1000

Quarters > 2 > income Statement > EBITDA

-3865000

Quarters > 2 > income Statement > operating Margin

-52.9459711224965

Quarters > 2 > income Statement > total Other Income Expense Net

343000

Quarters > 2 > balance Sheet > cash

1785000

Quarters > 2 > balance Sheet > short Term Investments

7000

Quarters > 2 > balance Sheet > receivables

4031000

Quarters > 2 > balance Sheet > inventories

6527000

Quarters > 2 > balance Sheet > total Current Assets

15332000

Quarters > 2 > balance Sheet > property Plant Equipment

772000

Quarters > 2 > balance Sheet > total Assets

16588000

Quarters > 2 > balance Sheet > payables

3300000

Quarters > 2 > balance Sheet > short Term Debt

426000

Quarters > 2 > balance Sheet > long Term Debt

4217000

Quarters > 2 > balance Sheet > total Liabilities

16119000

Quarters > 2 > balance Sheet > equity

469000

Quarters > 2 > cash Flow > net Income

-4203000

Quarters > 2 > cash Flow > depreciation

219000

Quarters > 2 > cash Flow > change In Working Capital

103000

Quarters > 2 > cash Flow > cash From Operations

-4117000

Quarters > 2 > cash Flow > capital Expenditures

3000

Quarters > 2 > cash Flow > cash From Investing

-3000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-4120000

Quarters > 2 > ratios > PE

-0.7619190571129304

Quarters > 2 > ratios > PB

9.561253536460553

Quarters > 2 > ratios > ROE

-896.1620469083156

Quarters > 2 > ratios > ROA

-25.33759344104172

Quarters > 2 > ratios > FCF

-4120000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-0.47973917093619

Quarters > 2 > health Score

9

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

12559000

Quarters > 3 > income Statement > cost Of Revenue

5272000

Quarters > 3 > income Statement > gross Profit

7287000

Quarters > 3 > income Statement > operating Expenses

8999000

Quarters > 3 > income Statement > operating Income

-1712000

Quarters > 3 > income Statement > interest Expense

55000

Quarters > 3 > income Statement > pretax Income

-1399000

Quarters > 3 > income Statement > net Income

-1396000

Quarters > 3 > income Statement > eps

-0.25306661996898666

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

5516334

Quarters > 3 > income Statement > income Tax Expense

-3000

Quarters > 3 > income Statement > EBITDA

-1123000

Quarters > 3 > income Statement > operating Margin

-13.63165857154232

Quarters > 3 > income Statement > total Other Income Expense Net

313000

Quarters > 3 > balance Sheet > cash

5905000

Quarters > 3 > balance Sheet > short Term Investments

7000

Quarters > 3 > balance Sheet > receivables

5315000

Quarters > 3 > balance Sheet > inventories

6646000

Quarters > 3 > balance Sheet > total Current Assets

20700000

Quarters > 3 > balance Sheet > property Plant Equipment

983000

Quarters > 3 > balance Sheet > total Assets

22101000

Quarters > 3 > balance Sheet > payables

1856000

Quarters > 3 > balance Sheet > short Term Debt

548000

Quarters > 3 > balance Sheet > long Term Debt

4098000

Quarters > 3 > balance Sheet > total Liabilities

17668000

Quarters > 3 > balance Sheet > equity

4433000

Quarters > 3 > cash Flow > net Income

-1396000

Quarters > 3 > cash Flow > depreciation

221000

Quarters > 3 > cash Flow > change In Working Capital

108000

Quarters > 3 > cash Flow > cash From Operations

-1017000

Quarters > 3 > cash Flow > capital Expenditures

1000

Quarters > 3 > cash Flow > cash From Investing

-1000

Quarters > 3 > cash Flow > cash From Financing

4050000

Quarters > 3 > cash Flow > net Change In Cash

3032000

Quarters > 3 > ratios > PE

-0.25306661996898666

Quarters > 3 > ratios > PB

1.0115560362282878

Quarters > 3 > ratios > ROE

-31.491089555605683

Quarters > 3 > ratios > ROA

-6.316456268947107

Quarters > 3 > ratios > FCF

-1018000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-0.08105740902938131

Quarters > 3 > health Score

17

Valuation > metrics > PE

-0.6169769909060616

Valuation > metrics > PB

-3.3941926125920183

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

257.61332816737695

Profitability > metrics > ROA

-46.13196419898703

Profitability > metrics > Net Margin

-0.9514882655981682

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-56.55855855855856

Risk > final Score

-196

Risk > verdict

High

Liquidity > metrics > Current Ratio

3.652559553978713

Liquidity > metrics > Quick Ratio

2.555499239736442

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

20

Prev Valuations > 2

80

Prev Profitabilities > 0

40

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-147

Prev Risks > 1

-146

Prev Risks > 2

-119

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T14:14:03.015Z